controlled attenuated parameter (cap) (Echosens North America)
90
Structured Review
Echosens North America
controlled attenuated parameter (cap)

Controlled Attenuated Parameter (Cap), supplied by Echosens North America, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/attenuation+parameter+cap/controlled+attenuated+parameter++cap+/pmc11334366-123-17-27
Average 90 stars, based on 1 article reviews

Controlled Attenuated Parameter (Cap), supplied by Echosens North America, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/attenuation+parameter+cap/controlled+attenuated+parameter++cap+/pmc11334366-123-17-27
Average 90 stars, based on 1 article reviews
controlled attenuated parameter (cap) - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial"
Article Title: Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial
Journal: BMC Pediatrics
doi: 10.1186/s12887-024-04993-8
Figure Legend Snippet: Patient characteristics at the baseline in tocotrienol-treated (TRF) and placebo group
Techniques Used: Activity Assay
Figure Legend Snippet: Comparisons of the changes from baseline to endpoint of study outcomes of NAFLD patients
Techniques Used: Activity Assay
Related Articles
Marker:Article Title: Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial Article Snippet: Using Activity Assay:Article Title: Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial Article Snippet: Using |